YTEN vs. RKDA, AAGR, EDBL, CTVA, FDP, AGRO, LND, LMNR, ALCO, and VFF
Should you be buying Yield10 Bioscience stock or one of its competitors? The main competitors of Yield10 Bioscience include Arcadia Biosciences (RKDA), African Agriculture (AAGR), Edible Garden (EDBL), Corteva (CTVA), Fresh Del Monte Produce (FDP), Adecoagro (AGRO), BrasilAgro - Companhia Brasileira de Propriedades Agrícolas (LND), Limoneira (LMNR), Alico (ALCO), and Village Farms International (VFF). These companies are all part of the "agricultural production - crops" industry.
Arcadia Biosciences (NASDAQ:RKDA) and Yield10 Bioscience (NASDAQ:YTEN) are both small-cap basic materials companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, analyst recommendations, community ranking, institutional ownership and risk.
Arcadia Biosciences received 64 more outperform votes than Yield10 Bioscience when rated by MarketBeat users. However, 60.55% of users gave Yield10 Bioscience an outperform vote while only 57.81% of users gave Arcadia Biosciences an outperform vote.
In the previous week, Arcadia Biosciences had 5 more articles in the media than Yield10 Bioscience. MarketBeat recorded 8 mentions for Arcadia Biosciences and 3 mentions for Yield10 Bioscience. Yield10 Bioscience's average media sentiment score of 0.93 beat Arcadia Biosciences' score of 0.67 indicating that Arcadia Biosciences is being referred to more favorably in the media.
Arcadia Biosciences has a beta of 0.62, indicating that its stock price is 38% less volatile than the S&P 500. Comparatively, Yield10 Bioscience has a beta of 1.68, indicating that its stock price is 68% more volatile than the S&P 500.
Arcadia Biosciences has higher revenue and earnings than Yield10 Bioscience. Arcadia Biosciences is trading at a lower price-to-earnings ratio than Yield10 Bioscience, indicating that it is currently the more affordable of the two stocks.
Arcadia Biosciences presently has a consensus target price of $6.00, indicating a potential upside of 96.08%. Yield10 Bioscience has a consensus target price of $84.00, indicating a potential upside of 4,297.91%. Given Arcadia Biosciences' higher possible upside, analysts clearly believe Yield10 Bioscience is more favorable than Arcadia Biosciences.
Yield10 Bioscience has a net margin of 0.00% compared to Yield10 Bioscience's net margin of -129.74%. Yield10 Bioscience's return on equity of -84.27% beat Arcadia Biosciences' return on equity.
17.7% of Arcadia Biosciences shares are held by institutional investors. Comparatively, 4.9% of Yield10 Bioscience shares are held by institutional investors. 1.8% of Arcadia Biosciences shares are held by insiders. Comparatively, 6.1% of Yield10 Bioscience shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Summary
Arcadia Biosciences beats Yield10 Bioscience on 11 of the 18 factors compared between the two stocks.
Get Yield10 Bioscience News Delivered to You Automatically
Sign up to receive the latest news and ratings for YTEN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding YTEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Yield10 Bioscience Competitors List
Related Companies and Tools
